IgE‐cross‐blocking antibodies to Fagales following sublingual immunotherapy with recombinant Bet v 1

Background Evidence has accumulated that birch pollen immunotherapy reduces rhinoconjunctivitis to pollen of birch homologous trees. Therapeutic efficacy has been associated with IgE‐blocking IgG antibodies. We have recently shown that sera collected after 16 weeks of sublingual immunotherapy with r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Allergy (Copenhagen) 2021-08, Vol.76 (8), p.2555-2564
Hauptverfasser:	Grilo, João Rodrigues, Kitzmüller, Claudia, Aglas, Lorenz, Sánchez Acosta, Gabriela, Vollmann, Ute, Ebner, Christof, Horak, Fritz, Kinaciyan, Tamar, Radauer, Christian, Ferreira, Fatima, Jahn‐Schmid, Beatrice, Bohle, Barbara
Format:	Artikel
Sprache:	eng
Schlagworte:	Allergens allergen‐specific immunotherapy Antibodies Antibodies, Blocking Antigens, Plant - immunology Antigens, Plant - therapeutic use Bet v 1 Bet v 1 antigen Biological activity birch pollen‐related allergy Blocking antibodies CD63 antigen cross‐blocking antibodies Enzyme-linked immunosorbent assay Fagales Homology Humans IgE‐blocking IgG antibodies Immunoglobulin E Immunoglobulin G Immunotherapy Leukocytes (basophilic) Oral administration Plant Proteins Pollen Recombinant Proteins Rhinoconjunctivitis Sublingual Immunotherapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!